Wolverine Trading, LLC Innoviva, Inc. Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $150,451 - $198,689	12,212 New	12,212 $195,000
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $162,645 - $228,145	-15,745 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$11.49 - $15.26 $2,355 - $3,128	-205 Reduced 1.29%	15,745 $223,000
Q1 2020 May 11, 2020	BUY	$8.11 - $15.23 $5,020 - $9,427	619 Added 4.04%	15,950 $185,000
Q4 2019 Feb 12, 2020	BUY	$10.28 - $14.38 $30,798 - $43,082	2,996 Added 24.29%	15,331 $217,000
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $168,866 - $247,440	12,335 New	12,335 $173,000
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $171,359 - $224,141	-12,275 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $19,518 - $22,482	1,432 Added 13.21%	12,275 $187,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $114,001 - $140,354	-8,261 Reduced 43.24%	10,843 $181,000
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $224,089 - $281,784	19,104	19,104 $271,000

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.